Next Article in Journal / Special Issue
TRPV Channels in Mast Cells as a Target for Low-Level-Laser Therapy
Previous Article in Journal
Receptor Tyrosine Kinases — Expanding Horizons
Previous Article in Special Issue
Unique Responses are Observed in Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and TRPV1) Co-Expressing Cells
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Liberati, S., et al. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression. Cells 2014, 3, 112–128

1
School of Pharmacy, Section of Experimental Medicine, University of Camerino, P.zza dei Costanti, 63032, Camerino, Macerata, Italy
2
Department of Molecular Medicine, Sapienza University, Viale Regina Elena 291, 00161, Rome, Italy
3
Medical Oncology, Polytechnic University of the Marche Region, Via Tronto 10, 60020, Ancona, Italy
4
Department of Medical Oncology, "Ospedali Riuniti" University Hospital, Polytechnic University of the Marche, Via Tronto 10/a, Torrette, Ancona, Italy
*
Author to whom correspondence should be addressed.
Cells 2014, 3(2), 660-661; https://doi.org/10.3390/cells3020660
Submission received: 12 June 2014 / Accepted: 16 June 2014 / Published: 20 June 2014
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels)
The authors wish to make the following corrections to this paper [1]:
On p.113, we say that: “The 33 mammalian TRPs identified thus far can be sorted into seven subfamilies: TRPC (Canonical), TRPM (Melastatin), TRPV (Vanilloid), TRPA (Ankyrin transmembrane protein), TRPP (Polycystin), TRPML (Mucolipin) and TRPN (NomPC-like).” However, TRPN channels have not yet been detected in mammals. Therefore, as of today, mammalian TRP channels belong to six subfamilies: TRP canonical (TRPC), TRP vanilloid (TRPV), TRP melastatin (TRPM), TRP ankyrin (TRPA), TRP polycystin (TRPP), and TRP mucolipin (TRPML).
These changes have no material impact on the conclusions of our paper.
The authors would like to apologize for any inconvenience this has caused the readers.

References

  1. Liberati, S.; Morelli, M.B.; Amantini, C.; Farfariello, V.; Santoni, M.; Conti, A.; Nabissi, M.; Cascinu, S.; Santoni, G. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression. Cells 2014, 3, 112–128. [Google Scholar] [CrossRef]

Share and Cite

MDPI and ACS Style

Liberati, S.; Morelli, M.B.; Amantini, C.; Farfariello, V.; Santoni, M.; Conti, A.; Nabissi, M.; Cascinu, S.; Santoni, G. Correction: Liberati, S., et al. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression. Cells 2014, 3, 112–128. Cells 2014, 3, 660-661. https://doi.org/10.3390/cells3020660

AMA Style

Liberati S, Morelli MB, Amantini C, Farfariello V, Santoni M, Conti A, Nabissi M, Cascinu S, Santoni G. Correction: Liberati, S., et al. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression. Cells 2014, 3, 112–128. Cells. 2014; 3(2):660-661. https://doi.org/10.3390/cells3020660

Chicago/Turabian Style

Liberati, Sonia, Maria Beatrice Morelli, Consuelo Amantini, Valerio Farfariello, Matteo Santoni, Alessandro Conti, Massimo Nabissi, Stefano Cascinu, and Giorgio Santoni. 2014. "Correction: Liberati, S., et al. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression. Cells 2014, 3, 112–128" Cells 3, no. 2: 660-661. https://doi.org/10.3390/cells3020660

Article Metrics

Back to TopTop